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There is evidence demonstrating variation in insulin sensitivity across the menstrual cycle. 
However, to date, research has yielded inconsistent results. 
Objective: 
This study investigated variation in insulin sensitivity across the menstrual cycle and 
associations with BMI, physical activity and cardiorespiratory fitness.  
Design: 
Data from 1906 premenopausal women in NHANES cycles 1999-2006 were analysed. 
Main outcome measures: 
Menstrual cycle day was assessed using questionnaire responses recording days since last 
period. Rhythmic variation of plasma glucose, triglyceride and insulin, homeostatic model of 
insulin resistance (HOMA-IR) and adipose tissue insulin resistance index (ADIPO-IR) across the 
menstrual cycle were analysed using cosinor rhythmometry. Participants were assigned low or 
high categories of BMI, physical activity and cardiorespiratory fitness and category membership 
included in cosinor models as covariates. 
Results: 
Rhythmicity was demonstrated by a significant cosine fit for glucose (p= 0.014) but not 
triglyceride (p= 0.369), insulin (p= 0.470), HOMA-IR (p=0.461) and ADIPO-IR (p= 0.335). When 
covariates were included, rhythmicity was observed when adjusting for: 1. BMI: glucose (p< 
0.001), triglyceride (p< 0.001), insulin (p< 0.001), HOMA-IR (p< 0.001) and ADIPO-IR (p< 
0.001); 2. Physical activity: glucose (p< 0.001), triglyceride (p= 0.006) and ADIPO-IR (p= 0.038); 












ADIPO-IR (p= 0.004). Triglyceride amplitude, but not acrophase, was greater in the high 
physical activity category compared to low (p=0.018).  
Conclusions: 
Rhythmicity in insulin sensitivity and associated metabolites across the menstrual cycle are 
modified by BMI, physical activity and cardiorespiratory fitness. 
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The onset and severity of insulin resistance are associated with a range of modifiable and non-
modifiable risk factors, including, sex, age, adiposity, physical inactivity and cardiovascular 
fitness (1,2). Women exhibit lower fasting plasma glucose levels, but greater impairment in 
glucose tolerance compared to men (3). Within adipose tissue, women have greater insulin 
stimulated glucose and fatty acid uptake compared to men (4). Whilst BMI and age are 
positively associated with insulin resistance, in women insulin resistance typically occurs at a 
higher BMI and higher age when compared with men (5). Moreover, low fitness has a greater 
association with insulin resistance in overweight women compared with overweight men (2).  
 
Reports have demonstrated a clear mechanistic role of sex hormones underpinning sexual 
dimorphism in insulin resistance (6). Insulin sensitivity has been positively associated with 
estradiol and negatively associated with progesterone in rats (7). This suggests that hormonal 
fluctuations across the menstrual cycle in humans may play a role in insulin sensitivity. 
However, strategies targeting the prevention and treatment of reduced insulin sensitivity rarely 
consider sex and none consider the role of the menstrual cycle.  
 
The menstrual cycle is a fundamental biological rhythmic cycle occurring in females of 
reproductive age, comprised of the ovarian and uterine cycles. The ovarian cycle, consisting of 
follicular, ovulatory and luteal phases is concerned with oocyte maturation and release, whilst 
the uterine cycle, consisting of menstruation, proliferative and secretory phases, is concerned 
with preparing the uterine lining for possible oocyte implantation in the event of fertilisation 
(8). The ovarian cycle and uterine cycle occur in a coordinated and concurrent manner; herein 












cycle length is 29 d, although this varies between individuals, with cycle lengths of 24-35 d 
considered normal and healthy (8,9). Within an individual, typical cycle length declines as age 
increases (9). The menstrual cycle is governed by rhythmic fluctuations of hormones within the 
hypothalamic-pituitary-gonadal axis; gonadotropin-releasing hormone, pituitary hormones 
(follicle stimulating hormone (FSH) and luteinizing hormone (LH)) and ovarian hormones 
(estradiol, progesterone and testosterone) (8). However, the effect of the menstrual cycle on 
physiology is under-researched and, in fact is frequently cited as a barrier towards the inclusion 
of women in research projects (10).  
 
Cyclical fluctuations in hormonal profiles across the menstrual cycle have been associated with 
alterations in metabolic control. During the luteal phase an increase in circulating insulin and 
reductions in circulating glucose and triglyceride have been observed (11,12). Correspondingly, 
insulin sensitivity would be expected to fluctuate across the menstrual cycle. However, studies 
so far have been equivocal. Reductions in insulin sensitivity during the luteal phase have been 
reported (12–18). However other studies document no change in insulin sensitivity across the 
menstrual cycle (19–22). These inconsistencies may be attributable to the relatively small 
sample sizes used in all but one (12) of these studies (n= 6-30), which lacked statistical power 
to robustly detect the small, yet clinically meaningful, changes in insulin sensitivity across the 
menstrual cycle. Yeung et al. used a large sample size (n= 259), and reported significant 
variation in insulin sensitivity across the menstrual cycle (12).  Moreover, previous studies 
recruited heterogenous study populations with varying BMI and physical activity levels, in 
which limited adjustment or investigation into the potentially confounding effects of these 
modifiable risk factors was conducted (12,21,22). Examining the role of modifiable risk factors 
in a large cohort of women is necessary to fully understand rhythmicity in insulin sensitivity 













In this study we firstly aim to characterise the variation in insulin sensitivity and associated 
metabolites across the menstrual cycle in a large cohort of well characterised females. Secondly, 
we will investigate the role of BMI, physical activity and cardiovascular fitness on variation in 
insulin sensitivity and associated metabolites across the menstrual cycle. 
Materials and methods: 
 
Participants: 
NHANES is a national, cross-sectional population-based study representative of the non-
institutionalised US civilian population (NHANES, RRID:SCR_013201). Data were collected in 2-
year cycles beginning in 1999, with data collection ongoing. NHANES participants completed an 
at-home interview and a physical examination at a mobile examination centre (MEC). A 
reproductive health questionnaire was included in data collection cycles between 1999-2006. 
This questionnaire was completed by 23,569 females. Participants were excluded if they had 
current diagnoses of metabolic disorder (diabetes, thyroid condition) or were taking medication 
that altered insulin sensitivity (Figure 1). Details of variable description and codes used in this 
study are provided in supplementary materials (23). 
 
Menstrual cycle assessment: 
Response to the question “number of days since last period started” was treated as day of 
menstrual cycle. Responses were collected once for each participant. Unfortunately data on 
typical menstrual cycle length were not available within the NHANES database. Participants 
were excluded from data analysis where reported number of days since last period started 
 35d. Whilst the typical menstrual cycle length is 29 d, a maximum cycle day value of 35 d was 












factors that influence the hormonal milieu across the menstrual cycle; <16 yr, currently taking 
hormonal contraceptive medication, currently pregnant or gave birth within the previous year. 
Final analyses were conducted on 1906 participants (Figure 1). 
 
Anthropometric assessment: 
Height was measured using a stadiometer and weight was measured using a digital scale 
following standard procedures at the MEC. BMI was calculated using weight in kilograms 
divided by height in metres squared (kg/m2). Prior to analyses participants were assigned to 
BMI defined categories based on standard cut-off thresholds (Low BMI- underweight and 
healthy weight 24.9 kg/m2; high BMI- overweight and obese >25 kg/m2) (24).  
 
Blood sampling and biochemical analysis: 
Venous blood samples were collected on the same day as the menstrual cycle questionnaire  
following a fast of at least 9 hr, but not more than 24 hr, by a trained phlebotomist at the MEC 
and processed according to a standardised protocol (25). Serum FSH and LH concentrations 
were analysed by microparticle Enzyme Immunoassay (Abbot Laboratories, Illinois, US) (26). 
Plasma glucose and triglyceride concentrations were analysed enzymatically (Roche Diagnostic 
Systems, New Jersey, US) (27,28). Plasma insulin concentration was assessed via 
radioimmunoassay (Pharmacia Diagnostics AB, Uppsala, Sweden) (29). Insulin sensitivity was 
calculated using the HOMA-IR (30) and ADIPO-IR (31) methods.  
Physical activity: 
Each participant completed a physical activity questionnaire which included questions relating 
to all physical activity performed in the previous 30 d.  Activity type, duration, intensity and 












defined as inducing light sweating or a slight to moderate increase in breathing or heart rate. 
Vigorous activities were defined as inducing heavy sweating or large increases in breathing or 
heart rate. MET scores for specific activities were calculated using activity type and intensity 
(32).  MET scores were multiplied by the average duration and number of times performed in 
the last 30 d to calculate MET min/30d for each activity. MET min/30d were summed for each 
activity then divided by 4.29 to calculate total MET min/wk. Prior to analyses participants were 
assigned to low and high physical activity categories based on whether they met the national 
physical activity guidelines (Low physical activity <500 MET/week; high physical activity   500 
MET/ week) (33). 
 
Cardiorespiratory fitness: 
Participants underwent a submaximal exercise test on a treadmill to predict  ̇O2max (34). 
Participants were assigned to 1 of 8 protocols, of varying difficulty, based on age, BMI and self-
reported physical activity level. Each protocol included a 2 min warm-up, 2 X 2 min stages and a 
2 min cool down. Heart rate was recorded throughout using an automated monitor. These 
exercise protocols aimed to elicit 75% of maximal heart rate by the end of the test. Predicted 
 ̇O2max was estimated by extrapolating age-specific maximal heart-rate responses to the two 2-
minute exercise stages, assuming a linear relation between HR and O2 consumption during 
exercise (35,36). Prior to analyses participants were assigned to low and high cardiorespiratory 
fitness categories based on whether their  ̇O2max score were below or above the age specific 
50th percentile (37).  
Statistical analysis: 
All analyses were conducted in R (V 3.6.3) (38). Participant demographic data are presented as 
mean ± sd. Number of participants are shown for each analysis; this varies due to missing data. 












normal data were log10 transformed. Rhythmicity across the menstrual cycle was detected 
using the “Cosinor” and “Cosinor2” packages (39,40). Cosinor fits a cosine curve with a free 
phase to data and calculates MESOR (a rhythm adjusted mean), amplitude (half the predictable 
variation within a cycle) and acrophase (time of highest value within a cycle). Peak to peak 
difference (%) (P-P) was calculated using the following equation: ((2 x amplitude/mean)*100). 
In separate Cosinor models, we included BMI, physical activity and cardiorespiratory fitness 
category as a covariate. Inclusion of covariates in the Cosinor model allows the MESOR, 
amplitude and acrophase to differ between respective high and low covariate categories. Overall 
significance of the cosine model was established using the zero-amplitude test. Wald tests were 
conducted to test for differences in the amplitude and acrophase between respective high and 





Participant characteristics are outlined in Table 1. As would be expected, greater weight, higher 
BMI, lower physical activity and lower  ̇O2max were observed in the low physical activity 
category (difference= 2.0 kg, p= 0.020; 1.2 kg/m2, p< 0.001, 2884.7 MET min/wk p< 0.001; 1.4 
ml/min/kg, p= 0.019 respectively), high BMI category (26.6 kg, p< 0.001; 10.3  kg/m2, p< 0.001; 
576.4 MET min/wk, p< 0.001; 2.5 ml/min/kg, p< 0.001) and low cardiorespiratory fitness 
category (3.4 kg, p= 0.003; 1.3 kg/m2, p= 0.001; 403.1 MET min/wk p= 0.028; 10.8 ml/min/kg, 
p< 0.001 respectively). Age was significantly greater for the low physical activity (3.1 yr, p< 
0.001), high BMI (3.6 yr, p< 0.001) and high cardiorespiratory fitness (5.5 yr, p< 0.001) 
categories. Height was significantly greater in the high physical activity category (1.5 cm, p 
<0.001), but not BMI (0.4 cm, p= 0.166) nor cardiorespiratory fitness (0.2 cm, p= 0.757). No 












0.15 kg/m2, p= 0.822), physical activity (1527.1± 182.1 MET min/wk, p= 0.199) or 
cardiorespiratory fitness (37.5 ± 0.5 ml/min/kg, p= 0.517) (23). 
 
Pituitary hormone concentration across the menstrual cycle: 
To demonstrate the validity of cosine analysis for analysing cyclic rhythms in variables across 
the menstrual cycle, pituitary hormones were analysed. Plasma FSH and LH concentrations 
were available for a subset of participants (Table 2 & Figure 2). FSH concentration reached a 
peak of 8.6 IU at day 9 falling to 3.5 IU at day 26 (p<.001). LH concentration peaked at 8.1 IU on 
day 12 and declined to a trough of 2.1 IU on day 29 (P<.001). 
 
What is the effect of the menstrual cycle on insulin sensitivity: 
Rhythmicity was demonstrated by a significant cosine fit for glucose (MESOR: 85.1 ± 
amplitude: 1.2 mmol/L; p= 0.014). No significant fit was observed for triglyceride (87.7 ± 2.8 
mg/dL; p= 0.369), insulin (9.8 ± 0.4 mmol/L; p= 0.470), HOMA-IR (2.1 ± 0.1 mmol/L; p= 0.461) 
or ADIPO-IR, (9.7 ± 0.6 mmol/L; p= 0.335) (Table 3; Figure 3 & 4). 
 
How does BMI affect insulin sensitivity across the menstrual cycle: 
When BMI category was added as a covariate into the cosine model, significant cosine fit was 
observed for glucose (p< 0.001), triglyceride (p< 0.001), insulin (p< 0.001), HOMA-IR (p< 0.001) 
and ADIPO-IR (p< 0.001) (Table 3; Figure 3 & 4). There were no significant differences in 
amplitude between low and high BMI categories for glucose (0.7 vs 1.7 mmol/L, p= 0.205), 
triglyceride (3.4 vs 3.9 mg/dL, p= 0.889), insulin (0.3 vs 1.1 mmol/L, p= 0.486), HOMA-IR (0.1 vs 












difference in acrophase between low and high BMI categories for glucose (12 vs 16 d, p= 0.335), 
triglyceride (28 vs 21 d, p= 0.098), insulin (15 vs 23 d, p= 0.180), HOMA-IR (15 vs 22 d, p= 
0.267) or ADIPO-IR (23 vs 22 d, p= 0.902).  
 
How does physical activity affect insulin sensitivity across the menstrual cycle: 
When physical activity category was added as a covariate into the cosine model, significant 
cosine fit was observed for glucose (p< 0.001), triglyceride (p= 0.006) and ADIPO-IR (P= 0.038), 
but not insulin (p= 0.095), HOMA-IR (p= 0.061) (Table 3; Figure 3 & 4). Triglyceride amplitude 
was significantly lower in the low physical activity category compared to the low physical 
activity category (3.1 vs 7.2 mg/dl, p= 0.018). No significant differences were observed in 
amplitude between low and high physical activity categories across the menstrual cycle for 
either glucose (1.5 vs 1.1 mmol/L, p= 0.308), insulin (0.7 vs 0.3 mmol/L, p= 0.284), HOMA-IR 
(0.2 vs 0.1 mmol/L, p= 0.310) or ADIPO-IR (0.7 vs 0.7 mmol/L, p= 0.506). There were no 
significant differences in acrophase between low and high BMI categories for glucose (17 vs 12 
d, p= 0.235), triglyceride (12 vs 27 d, p= 0.675), insulin (21 vs 14 d, p= 0.571), HOMA-IR (21 vs 
14 d, p= 0.577), ADIPO-IR (18 vs 26 d, p= 0.423). 
 
How does cardiorespiratory fitness affect insulin sensitivity across the menstrual cycle: 
When cardiorespiratory fitness category was added as a covariate into the cosine model, 
significant cosine fit was observed for triglyceride (p= 0.041), insulin (p= 0.002), HOMA-IR (p= 
0.004) and ADIPO-IR (p= 0.004), but not glucose (p= 0.223) (Table 3; Figure 3 & 4). No 
significant differences in amplitude across the menstrual cycle were observed between low and 
high cardiorespiratory fitness for glucose (0.4 vs 0.8 mmol/L, p= 0.460), triglyceride (6.9 vs 6.0 
mg/dL, p= 0.116), insulin (1.2 vs 0.7 mmol/L, p =0.099), HOMA-IR (0.3 vs 0.2 mmol/L, p= 












acrophase between low and high BMI categories for glucose (20 vs 12 d, p= 0.443), triglyceride 
(34 vs 24 d, p= 0.271), insulin (27 vs 17 d, p= 0.290), HOMA-IR (27 vs 17 d, p= 0.282) or ADIPO-




This study aimed to characterise cyclical changes in insulin sensitivity and associated metabolic 
parameters across the menstrual cycle and their association with BMI, physical activity and 
cardiorespiratory fitness. We found rhythmic cycling across the menstrual cycle for glucose, but 
not triglyceride, insulin, HOMA-IR or ADIPO-IR. When including selected risk factors for insulin 
resistance as covariates, rhythmic cycling was observed across the menstrual cycle for glucose, 
triglyceride, insulin, HOMA-IR, and ADIPO-IR when models included BMI; glucose, triglyceride 
and ADIPO-IR when models included physical activity; and triglyceride, insulin, HOMA-IR and 
ADIPO-IR when models included cardiorespiratory fitness. Triglyceride amplitude, but not 
acrophase, was significantly greater in the high physical activity category compared to the low 
physical activity category. No significant differences in amplitude nor acrophase were observed 
for glucose, insulin, HOMA-IR and ADIPO-IR between respective high and low covariate 
categories. These findings demonstrate changes in insulin sensitivity and triglyceride levels 
across the menstrual cycle are modified by BMI, physical activity and cardiorespiratory fitness 
status.  
 
Previous literature reports insulin sensitivity is either reduced during the luteal phase (12–18) 
or remains unchanged across the menstrual cycle (19–22). Reported variation in HOMA-IR 
across the menstrual cycle is of a relatively small magnitude (0.3 U), although may be clinically 
meaningful (12). Therefore, some previous studies using small sample sizes may have lacked 












another large study, we did not observe rhythmic variation for insulin sensitivity prior to 
adjusting cosine fit for BMI or cardiorespiratory fitness (12). Participants studied in Yeung et al. 
had an average lower BMI (24.1 vs 26.3 kg/m2) which may have contributed to discrepancies in 
findings (12). Cardiorespiratory fitness was not assessed in their study. Following the inclusion 
of BMI and cardiorespiratory fitness into models, we observed rhythmic cycling for HOMA-IR 
with similar variability across the menstrual cycle of 0.2 U (P-P = 7.5%), to that previously 
reported by Yeung et al.. This provides evidence that BMI and cardiorespiratory fitness mediate 
the variation in HOMA-IR across the menstrual cycle. This mediation effect may underpin 
inconsistencies reported in the literature.  
 
To our knowledge, this is the first study to investigate ADIPO-IR across the menstrual cycle. We 
observed rhythmic variation in ADIPO-IR when adjusting for BMI, physical activity and 
cardiorespiratory fitness levels. Rhythmic cycling in ADIPO-IR concentration roughly coincided 
with rhythmic cycling of triglyceride across the menstrual cycle, which peaked at cycle day 23 
declining to a trough at cycle day 5 (Table 3). This contradicts previous research, reporting 
elevated triglyceride concentrations during the follicular phase compared to the luteal phase 
(11,41). However, previous studies did not consider BMI, physical activity or cardiorespiratory 
fitness, which we found significantly mediated rhythmicity in triglyceride across the menstrual 
cycle. Additionally, we used a larger sample size in this study compared previous studies (n= 34 
(41) & 259 (11) vs 869). Increases in ADIPO-IR during the luteal phase alongside concurrent 
elevations in triglyceride concentration, may be underpinned by a decline in insulin stimulated 
triglyceride uptake or suppression of lipolysis during the luteal phase. Progesterone has been 
shown to inhibit adipocyte insulin signalling and receptor binding (42,43). Increased circulating 
progesterone levels may contribute to increased ADIPO-IR observed during the luteal phase of 
the menstrual cycle.  However, further work is required to elucidate the role progesterone plays 













We observed lower mean triglyceride concentration alongside significantly greater amplitude 
across the menstrual cycle in the high physical activity category compared to low. The timing of 
the peak and trough in triglyceride concentration roughly coincided with the glucose trough and 
peak, respectively. Regular physical activity increases the capacity for adipose tissue and 
skeletal muscle lipid uptake and mobilisation (4,44). Moreover, high physical activity levels are 
positively associated with increased metabolic flexibility (44). Greater amplitude in triglyceride 
concentration across the menstrual cycle in the high physical activity category may reflect a 
coordinated uptake and release of triglyceride in response to fluctuations in glucose 
concentration. 
 
Whilst BMI and physical activity are significantly associated with variation in HOMA-IR and 
ADIPO-IR across the menstrual cycle, the mechanisms underpinning this relationship are 
uncertain. Variation in insulin sensitivity across the menstrual cycle has been associated with 
progesterone and estradiol (12). Differences in BMI and physical activity are known to alter 
ovarian hormonal profiles. Low physical activity levels are associated with higher mean 
estradiol levels across the menstrual cycle and higher progesterone levels during the luteal 
phase (45). High BMI is associated with greater variability of estradiol, but not progesterone 
(46). Unfortunately, neither estradiol nor progesterone were assessed in NHANES. Future 
research should investigate the role of sex hormones in the relationship between insulin 
sensitivity and BMI and physical activity levels. 
 
We observed significant rhythmicity in HOMA-IR and ADIPO-IR following adjustment for BMI 
and cardiorespiratory fitness. This suggests that menstrual cycle phase is an important 












in populations with high BMI or low cardiorespiratory fitness. Additionally, we found greater 
amplitude across the menstrual cycle for  HOMA-IR and glucose in high compared to low BMI 
and HOMA-IR in low compared to high cardiorespiratory fitness. Whilst these amplitudes were 
not statistically significant, these data indicate individuals with high BMI or low 
cardiorespiratory fitness may be at greater risk of impaired insulin sensitivity and elevated 
glucose concentration during the luteal phase. Therefore, therapeutic strategies aiming to 
reduce disturbances in metabolic control across the menstrual cycle may benefit from targeting 
a reduction in BMI and increase in cardiovascular fitness. This is of particular clinical 
importance due to the role of high glucose variability and insulin resistance in the development 
and progression of diabetic complications (47,48). Future larger studies should further 
investigate the association between BMI and cardiorespiratory fitness with the magnitude of 
variation in insulin sensitivity and glucose concentrations across the menstrual cycle. This 
research is crucial to further understand the role of the menstrual cycle in diabetes.  
 
Unexpectedly, some participant demographics were significantly different between respective 
low and high demographic categories. Therefore, some caution should be applied when 
interpreting these findings. Age was significantly greater in high BMI, physical activity and 
cardiorespiratory fitness categories compared to low. However, previous research has reported 
the positive relationship between age and insulin resistance is associated with concurrent 
increases in adiposity and decreases in physical activity (49), which were included in the 
cosinor analysis as covariates. Height was significantly greater in the high physical activity 
group. We performed regression analysis to assess the relationship between height and 
metabolic outcome parameters whilst accounting for menstrual cycle day and found no 
significant associations (23). This statistically significant effect may simply be due to the 
number of participants in the study (50). Similarly, a previous large study reported no 












would expect there to be overlap in participants within covariate categories, which may have 
confounding effects. For example, commonality between participants in the high BMI, low 
physical activity and low cardiorespiratory categories. Future studies should investigate 
whether there is a cumulative effect of BMI, physical activity and cardiorespiratory on rhythmic 
cycling in insulin resistance across the menstrual cycle. 
 
The large, prospective nature of the NHANES data set represents a major strength of this study. 
Our analyses were conducted in 1906 female participants with detailed questionnaire data 
available for reproductive and general health. These data permitted the exclusion of women 
with conditions that alter metabolic control or hormonal concentrations. The indirect 
assessment of insulin resistance using surrogate measures (HOMA-IR and AIDIPO-IR) was a 
limitation. However, HOMA-IR and ADIPO-IR have been validated against the gold standard 
hyperinsulinaemic euglycaemic clamp (r= 0.82, p< 0.001) and the multi-step pancreatic clamp 
(r= 0.86, p< 0.001) respectively, demonstrating strong correlations (45, 57). Physical activity 
levels were determined using questionnaire. However, reports from the NHANES data set 
demonstrate similar amounts of self-reported physical activity and objectively measured 
physical activity via accelerometer in those either meeting or not meeting PA guidelines (53). 
Nonetheless, future studies may benefit from collecting objectively measured physical activity 
across the menstrual cycle.  This study used number of days since last menstrual period started 
as a proxy for phase of menstrual cycle and was limited by a lack of data regarding participants’ 
typical menstrual cycle length. These data would allow greater accuracy in determining 
menstrual cycle phase. However, that the analysis of FSH and LH displayed expected 
fluctuations with significant rhythmicity across the menstrual cycle supports the use of “number 
of days since last menstrual period started” for statistical analysis in this data set. Ovarian 
hormone concentrations across the menstrual cycle were not measured, which would allow 












metabolic dysregulation. Future studies should obtain further data to allow thorough 
characterisation of participants’ menstrual cycles, including typical menstrual cycle duration, 
ovulation date and ovarian hormones. 
 
In conclusion, our study confirms previous reports showing insulin sensitivity undergoes small, 
yet statistically and clinically significant, rhythmic cycling across the menstrual cycle. This is the 
first study to demonstrate a modifying effect of BMI, physical activity and cardiorespiratory 
fitness on variation in insulin sensitivity and associated metabolites across the menstrual cycle. 
These findings provide a basis for further research to explore the mediatory role of BMI, 
physical activity and cardiorespiratory fitness on variation in insulin sensitivity across the 
menstrual cycle. Furthermore, this provides direction for investigation into the therapeutic 
benefit of targeting BMI and physical activity to mitigate disturbances in insulin sensitivity 
















All data generated or analysed during this study are included in this published article or in the 
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Legends for Figures and Tables: 
 
Figure 1: Flowchart depicting participant selection in the study. Dotted lines represent 
participant exclusion. 
 
Figure 2: Boxplot with cosine wave showing pituitary hormone concentration across the 
menstrual cycle. A, follicle stimulating hormone. B, luteinizing hormone. 
 
Figure 3: Changes in glucose, triglyceride and insulin across the menstrual cycle with low and 
high categories of BMI (left), cardiorespiratory fitness (middle) and physical activity (right). 
Boxplot represents all participants data for respective variable. Cosinor model fits are shown for 
all participants (blue), low covariate category (green) and high covariate category (red). Low 
BMI, ≤24.9 kg/m2; high BMI > 25 kg/m2; low cardiorespiratory fitness, ≤50th age specific 
percentile; high cardiorespiratory fitness >50th age specific percentile; low physical activity, 
≤500 MET min/wk; high physical activity, > 500 MET min/wk.  
 
Figure 4: Changes in HOMA-IR and ADIPO-IR across the menstrual cycle with low and high 
categories of BMI (left), cardiorespiratory fitness (middle) and physical activity (right). Boxplot 
represents all participants data for respective variable. Cosinor model fits are shown for all 
participants (blue), low covariate category (green) and high covariate category (red). Low BMI, 
≤24.9 kg/m2; high BMI > 25 kg/m2; low cardiorespiratory fitness, ≤50th age specific percentile; 
high cardiorespiratory fitness >50th age specific percentile; low physical activity, ≤500 MET 












Table 1: Data are presented as mean ± standard deviation. N-values are presented as total (%) 
for each demographic category. PA, physical activity; BMI, body mass index; CRF, 
cardiorespiratory fitness. * represents p <0.05 following independent samples t test.   
 
Table 2: FSH, follicle stimulating hormone; LH , luteinizing hormone; P-P (%), difference 
between peak and trough. P-value from zero amplitude test for model fit. 
 
Table 3: BMI, body mass index; CRF, cardiorespiratory fitness; PA, physical activity. Low BMI, 
 24.9 kg/m2; high BMI > 25 kg/m2; low CRF,  50th age specific  ̇O2max percentile; high CRF 
>50th specific  ̇O2max percentile; low PA,  500 MET min/wk; high PA, > 500 MET min/wk. 
Cosine fit p-value represents zero amplitude test for model fit. Amplitude difference p-value 
represents difference in amplitudes between respective low and high covariate categories. 
Acrophase difference p-value represents difference in acrophase between respective low and 














Table 1: Participant characteristics split by demographic category. 
 
Demographic All Low MET High MET Low BMI High BMI Low CRF High CRF 
n 1906 946 (49.6) 960 (50.4) 1021 (53.6) 885 (46.4) 451 (46.7) 514 (53.2) 
Age (yr) 25.4 ± 9.4 27.0 ± 10.0 23.9 ± 8.6* 23.8 ± 8.5 27.4 ± 10.1* 21.3 ± 5.9 26.8 ± 10.0* 
Height (cm) 161.8 ± 6.9 161.1 ± 6.9 162.6 ±6.8* 162.0 ± 6.8 161.6 ± 7.0 162.0 ± 6.7 162.2 ± 6.7 
Weight (kg) 69.0 ± 19.0 70.0 ± 19.9 68.0 ± 18.0* 56.6 ± 7.2 83.2 ± 18.3* 69.5 ± 19.5 66.1 ± 15.1* 
BMI (kg/m2) 26.3 ± 6.8 26.9 ± 7.2 25.7 ± 6.3* 21.5 ±2.1 31.8 ± 6.1* 26.4 ± 7.0 25.1 ± 5.4* 
VO2max (ml/kg/min) 37.5 ± 9.0 36.8 ± 9.5 38.2 ± 8.6* 38.6 ± 8.8 36.1 ± 9.1* 31.8 ± 3.8 42.6 ± 9.3* 


























FSH 218 5.5 2.5 91.9 9 26 < 0.001 













































83.41 0.67 1.62 12    
 High 
BMI 
884 87.07 1.69 3.88 16 0.000 0.205 0.335 
 Low PA 944 85.82 1.46 3.41 17    
 High PA 959 84.35 1.10 2.61 12 0.000 0.308 0.235 
 Low CRF 451 84.16 0.44 1.05 20    
  High 
CRF 
513 84.44 0.78 1.86 12 0.223 0.460 0.443 
Triglycerid
e 
All 872 87.67 2.79 6.37 26 0.369   
 Low 
BMI 





3.85 7.51 21 0.000 0.889 0.098 
 Low PA 404 89.83 3.07 6.85 12    
 High PA 468 86.39 7.22 16.7
3 
27 0.006 0.018 0.675 
 Low CRF 192 88.14 6.87 15.5
8 
34    
  High 
CRF 
254 83.39 6.03 14.4
7 
24 0.041 0.116 0.271 
Insulin All 872 9.75 0.37 7.63 20 0.470   
 Low 
BMI 
483 7.49 0.30 8.14 15    













 Low PA 405 10.06 0.67 13.3
2 
21    
 High PA 467 9.45 0.26 5.59 14 0.095 0.284 0.571 
 Low CRF 194 10.89 1.22 22.4
9 
27    
  High 
CRF 
252 9.04 0.71 15.6
0 
17 0.002 0.099 0.290 
HOMA-IR All 871 2.09 0.09 8.34 20 0.461   
 Low 
BMI 
482 1.56 0.05 6.90 15    
 High 
BMI 
389 3.01 0.28 18.9
1 
22 0.000 0.318 0.267 
 Low PA 404 2.18 0.15 14.1
8 
21    
 High PA 467 2.01 0.06 6.03 14 0.061 0.310 0.577 
 Low CRF 194 2.30 0.27 23.2
1 
27    
  High 
CRF 
252 1.92 0.16 16.7
5 
17 0.004 0.109 0.282 
ADIPO-IR All 868 9.67 0.59 12.2
4 
23 0.335   
 Low 
BMI 
480 6.53 0.23 7.09 23    
 High 
BMI 
388 15.71 1.89 24.0
9 
22 0.000 0.248 0.902 
 Low PA 403 10.24 0.72 14.0
2 
18    
 High PA 465 9.22 0.68 14.8
2 
26 0.038 0.506 0.423 
 Low CRF 192 10.81 1.71 31.6
4 
30    
  High 
CRF 
252 8.54 1.04 24.4
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